Related Experiment Videos
Luteolin as a Cancer Therapeutic: From Preclinical Evidence to Translational Potential
Sreemoyee Mitra1, Priya Manna2, Dipanjan Karati3
1Department of Pharmaceutical Technology, ISF College of Pharmacy, Moga, Punjab, India.
Abstract:
Cancer, a condition marked by the atypical development and multiplication of cells that may acquire aggressive properties, ranks among the foremost causes of mortality globally. Because of the problems with existing chemotherapy medications, cancer therapeutic research is being conducted to find substitute treatment approaches that are less harmful to healthy cells. The application of flavonoids has become a prominent area of interest in cancer therapy research. Luteolin, 3',4',5,7-tetrahydroxyflavone, is a common flavonoid that may be found in many plants and medicinal herbs. Luteolin-rich plants have been used to cure a variety of illnesses, including cancer, inflammatory conditions, and hypertension. Targeting cellular processes such as apoptosis, angiogenesis, migration, and cell cycle progression, luteolin's anticancer properties have been thoroughly studied in a variety of cancer types. It interacts with several proteins and signaling pathways to accomplish this. The development of contemporary luteolin research is outlined in this study, with an emphasis on preclinical data and translational prospects. This article reveals the chemistry, structure-activity relationship, and extraction techniques of luteolin. It explores pharmacological activities, mechanism of action, and advancements in nanoformulation strategies. Furthermore, it explains how luteolin's potential as a cancer treatment is demonstrated from preclinical proof to translational capability.
Insights
Luteolin, a plant-derived flavonoid, shows significant anticancer potential by targeting key cellular processes. This research explores its chemistry, pharmacology, and nanoformulations for improved cancer therapy, highlighting preclinical evidence and translational prospects.
Area of Science:
- * Natural Product Chemistry
- * Pharmacology and Toxicology
- * Cancer Biology and Therapeutics
Background:
- * Cancer remains a leading global cause of mortality, driving the search for novel, less toxic therapeutic agents.
- * Flavonoids, particularly luteolin (3',4',5,7-tetrahydroxyflavone), are gaining attention for their potential anticancer properties.
- * Existing chemotherapy limitations necessitate research into alternative treatments with improved safety profiles.
Purpose of the Study:
- * To review contemporary research on luteolin's anticancer potential, focusing on preclinical data and translational applications.
- * To elucidate the chemistry, structure-activity relationships, extraction methods, and pharmacological activities of luteolin.
- * To explore luteolin's mechanisms of action, nanoformulation strategies, and overall therapeutic prospects in cancer treatment.
Main Methods:
- * Comprehensive literature review of preclinical studies on luteolin's anticancer effects.
- * Analysis of luteolin's chemical properties, extraction techniques, and structure-activity relationships.
- * Investigation into luteolin's pharmacological activities and mechanisms of action, including effects on apoptosis, angiogenesis, migration, and cell cycle.
Main Results:
- * Luteolin exhibits anticancer properties by targeting critical cellular processes like apoptosis, angiogenesis, migration, and cell cycle progression.
- * The study details luteolin's chemistry, extraction, structure-activity relationships, and pharmacological actions.
- * Advancements in nanoformulation strategies for luteolin are explored, enhancing its therapeutic delivery and efficacy.
Conclusions:
- * Luteolin demonstrates significant potential as a cancer therapeutic agent, supported by extensive preclinical evidence.
- * Further research and development, particularly in nanoformulation, are crucial for translating luteolin's potential into clinical applications.
- * Luteolin represents a promising natural compound for developing safer and more effective cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:59Cancer Prevention
Some...
02:39lncRNA - Long Non-coding RNAs
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...